Vis enkel innførsel

dc.contributor.authorRisvoll, Hilde
dc.contributor.authorMusial, Frauke
dc.contributor.authorHalvorsen, Kjell H.
dc.contributor.authorGiverhaug, Trude
dc.contributor.authorWaaseth, Marit
dc.date.accessioned2019-11-11T14:18:31Z
dc.date.available2019-11-11T14:18:31Z
dc.date.issued2019-07-19
dc.description.abstract<p><i>Background - </i>Community-dwelling persons with dementia commonly use dietary supplements (DS), often without receiving help with the administration. Patient safety is a concern, as DS-drug interactions and adverse events are potential complications. Since many persons with dementia buy their DS in pharmacies, we investigated Norwegian pharmacy employees’ attitudes and professional practice behaviors related to DS. <p><i>Methods - </i>We conducted a survey in eight Norwegian municipalities of pharmacy employees involved in the sale of DS. The questionnaire covered demographics and investigated attitudes toward DS, professional practice behaviors related to the sale of DS, experiences with customers with dementia, and perceived and attributed responsibilities with regard to patient safety. <p><i>Results - </i>One hundred and five employees responded (response rate: 52%). Most employees regarded general practitioners (GPs) as primarily responsible for safeguarding the use of DS by persons with dementia and rated themselves less responsible. Thirty-seven percent of the employees reported personal use of DS (past or current use). Nine percent considered some of the DS to have symptomatic or prophylactic effects against dementia. Forty-eight percent confirmed that they informed customers about potential adverse events; 42% indicated that they did this sometimes. Sixteen percent checked regularly for DS-drug interactions, and two-thirds checked depending on the customers’ health, the type of drug or the type of DS. One-quarter regularly asked about the co-use of prescription drugs (PD) when selling DS, while only 2% asked about the co-use of DS when dispensing PD. Only 25% reported access to independent scientific information on all or most DS sold in their pharmacy. Eight percent had experienced unsafe use of DS by persons with dementia. Six percent had been taught about counselling persons with dementia. Education level influenced professional practice behavior to some extent. <p><i>Conclusion - </i>Pharmacy employees do not see themselves as primarily responsible for the safe use of DS by persons with dementia. Moreover, they have limited experience with the unsafe use of DS by these persons. There is potential for improvement regarding tools and educational interventions for pharmacy employees to provide sufficient help to persons with dementia who use DS.en_US
dc.identifier.citationRisvoll, H., Musial, F., Halvorsen, K.H., Giverhaug, T. & Waaseth, M. (2019). Pharmacy employees' involvement in safeguarding persons with dementia who use dietary supplements: Results from a survey of Norwegian pharmacies. <i>BMC Complementary and Alternative Medicine, 19</i>(1), 179. https://doi.org/10.1186/s12906-019-2587-4en_US
dc.identifier.cristinIDFRIDAID 1744035
dc.identifier.doi10.1186/s12906-019-2587-4
dc.identifier.issn1472-6882
dc.identifier.urihttps://hdl.handle.net/10037/16646
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.relation.ispartofRisvoll, H. (2023). Health care professionals’ caretaking of persons with dementia who use dietary supplements. (Doctoral thesis). <a href=https://hdl.handle.net/10037/31268>https://hdl.handle.net/10037/31268</a>.
dc.relation.journalBMC Complementary and Alternative Medicine
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Geriatrics: 778en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Geriatri: 778en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Health service and health administration research: 806en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en_US
dc.titlePharmacy employees' involvement in safeguarding persons with dementia who use dietary supplements: Results from a survey of Norwegian pharmacies.en_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel